Dysregulated MVP contributes to tumor progression and chemotherapy resistance by increasing the levels of several important lipid compounds, including CHO, isoprenoid lipid anchors such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), and non-steroidal isoprenoids such as heme A of cytochrome c oxidase, dolichol, and ubiquinone [19]. This evidence concerns the gene MVP and neoplasm.